106 Pharmacokinetic variability of clarithromycin is due to differences in CYP3A4 activity in patients with cystic fibrosis (CF) – a reason for treatment failure?

✍ Scribed by C.S. Dalbøge; X.C. Nielsen; K. Dalhoff; M. Dunø; A. Buchara; J.-W.C. Alffenaar; T. Pressler; N. Høiby; H.K. Johansen

• Book ID: 118643014
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 48 KB
• Volume: 10
• Category: Article
• ISSN: 1569-1993
• DOI: 10.1016/s1569-1993(11)60123-9